CN102475852A - 一种治疗颈椎病的中药制剂 - Google Patents
一种治疗颈椎病的中药制剂 Download PDFInfo
- Publication number
- CN102475852A CN102475852A CN2010105697521A CN201010569752A CN102475852A CN 102475852 A CN102475852 A CN 102475852A CN 2010105697521 A CN2010105697521 A CN 2010105697521A CN 201010569752 A CN201010569752 A CN 201010569752A CN 102475852 A CN102475852 A CN 102475852A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- cervical spondylosis
- traditional chinese
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims abstract description 12
- 208000036319 cervical spondylosis Diseases 0.000 title claims abstract description 12
- 208000005801 spondylosis Diseases 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title claims abstract description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 241000903946 Clematidis Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 239000004863 Frankincense Substances 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 18
- 230000036407 pain Effects 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 241000411851 herbal medicine Species 0.000 abstract description 5
- 210000002435 tendon Anatomy 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 241000227129 Aconitum Species 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 240000002624 Mespilus germanica Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 208000006820 Arthralgia Diseases 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 229930013930 alkaloid Natural products 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 229930183118 Tanshinone Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 2
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229940039750 aconitine Drugs 0.000 description 2
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- -1 di esters alkaloid Chemical class 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- JLUQTCXCAFSSLD-NXEZZACHSA-N Anemonin Chemical compound C1=CC(=O)O[C@]11[C@@]2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-NXEZZACHSA-N 0.000 description 1
- JLUQTCXCAFSSLD-UHFFFAOYSA-N Anemonin Natural products C1=CC(=O)OC11C2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- DCTLJGWMHPGCOS-UHFFFAOYSA-N Osajin Chemical compound C1=2C=CC(C)(C)OC=2C(CC=C(C)C)=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DCTLJGWMHPGCOS-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- OUZCFMSJGDEXRT-UHFFFAOYSA-N Scandinone Natural products O=C1C=2C(OC)=C(CC=C(C)C)C=3OC(C)(C)C=CC=3C=2OC=C1C1=CC=C(O)C=C1 OUZCFMSJGDEXRT-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000009806 pulsatillae Substances 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗颈椎病的中药制剂,属于中药制剂技术领域。它主要由葛根、威灵仙、枸杞子、天麻、川乌、草乌等十六味中草药构成。本发明具有祛风散寒、疏经通络、补益肝肾、调和气血、舒筋止痛的功效,对颈椎病疗效确切,服用简便,容易推广。
Description
所属技术领域
本发明属于中药制剂技术领域。
背景技术
颈椎病是一种常见病和多发病。现代社会,随着文明程度的提高,患颈椎病的人越来越多。对颈椎病的治疗,一般有药物治疗、手术治疗、针灸治疗及一些康复治疗如推拿按摩等。这些疗法,各有短长,疗效却都不理想。
发明内容
为了克服现有技术的不足,本发明提供一种新的能治疗颈椎病的中药制剂,达到具有疗效确切、无毒副作用、服用简便、作用快捷、容易推广的目的。
本发明解决其技术问题所采用的技术方案是:
本发明由葛根、威灵仙、枸杞子、天麻、川乌、草乌、羌活、独活、丹参、红花、细辛、桂枝、川芎、冰片、乳香、没药十六味中草药构成。
本发明有关药物成分主要功能与配制
本发明制剂中的葛根,性味甘、辛、平,含淀粉、异黄酮类、生物碱等。解肌、退热、生津、止渴。主治头痛发热、项痛强、烦渴泄泻、麻疹不透。是本发明的主要成分。
本发明制剂中的威灵仙,性味辛、咸、温,含白头翁脑及白头翁醇、甾醇、糖类及皂甙等。祛风湿、止痛、化鱼骨。主治风湿痹痛、腰膝及四肢疼痛,症瘕积聚。
本发明制剂中的枸杞子,性味甘、平,含甜菜碱、胡萝卜素、核黄素、脂肪油、烟酸、维生素A、酸浆红素、钙、磷、铁等。滋肾润肺,养肝明目。主治肝肾阴虚,腰膝酸软,目昏多泪,虚劳咳嗽,消渴遗精。
本发明制剂中的天麻,性味辛、温,含粘液质、生物碱、甙类、维生素A。祛风湿、定惊痫。主治头昏眩晕,半身不遂,风寒痹痛,四肢拘挛,惊风癫痫。
本发明制剂中的川乌,性味大辛、大热、有毒,含多种双酯类生物碱,如次乌头碱、乌头碱及中乌头碱等。温中、散寒、镇痛。主治风寒湿痹、关节疼痛、手足拘挛、半身不遂等。
本发明制剂中的草乌,性味辛、温,有毒,含多种双酯类生物碱,如中乌头碱、次乌头碱及乌头碱等。祛风、燥湿、止痛。主治风湿寒痹,骨节酸痛,四肢麻木,腰腹痛。
本发明制剂中的羌活、性味辛、苦、温,含挥发油。发汗解表,搜风胜湿。主治感冒风寒,头痛无汗,周身肢节痛,风湿痹痛。
本发明制剂中的独活,性味辛、苦、温,含挥发油。祛风胜湿,散寒止痛。主治风湿痹痛,腰膝酸痛,四肢麻木。
本发明制剂中的丹参,性味苦、温,含丹参酮甲,丹参酮乙,丹参酮丙,色素,维生素E等。去瘀生新,活血调经,安神宁心,益气养血。主治心绞痛,心腹邪气,月经不调,痛经,经闭,瘀血腹痛。
本发明制剂中的红花、性味辛、温,含红花黄色素,红花甙,异红花红色素等。活血破瘀,通经止痛。主治经闭,症瘕,难产,死胎,产后恶露不止,跌打损伤,瘀血作痛。
本发明制剂中的细辛,性味辛、微温,含挥发油等。散风,开窍。主治牙痛,头痛,风湿痹痛,痰饮喘咳。
本发明制剂中的桂枝,性味辛、甘、温,含挥发油,主要为桂皮醛。发汗解肌,温经通脉。主治风寒表症,肩臂肢节酸痛,经闭腹痛等。
本发明制剂中的川芎,性味辛、温,含挥发油、挥发性油状生物碱、酚性成分、内脂类、阿魏酸等。行气开郁,祛风燥湿,活血止痛。主治风冷头痛眩晕,胁疼腹痛,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。
本发明制剂中的冰片,性味辛、苦、微寒,含右旋龙脑。通窍散火,明目止痛。主治中风口禁,惊痫痰迷,喉痹齿痛,口疮,疮疡,目赤翳膜。
本发明制剂中的乳香,性味辛、苦、温,含树脂、树胶、挥发油。调气活血,舒筋止痛,消痈疽。主治心腹诸痛,筋脉拘挛,跌打损伤,痈疽疮毒。
本发明制剂中的没药,性味苦、平,含树脂、树胶、挥发油、蛋白质等。行气、活血、通经、止痛。主治痈疽肿痛,跌打瘀血,胸腹诸痛,经闭症瘕。
上述本发明16种中草药含有多种对颈椎病有良好治疗作用的化学元素。通过古法和特殊方法炮制,以及组合加工制剂,产生一系列理化和生化反应,并通过药物成分间的协同作用,产生良好的治疗效果。本发明的有益效果是:具有祛风散寒、补益肝肾、调和气血、疏经通络、舒筋止疼的功能,可有效地防治颈椎病;使用本发明,可以达到疗效确切,无毒副作用,服用简便,作用快捷,容易推广的目的。
具体实施方式
1.配方比例
葛根15%,威灵仙8%,枸杞子6%。天麻6%,川乌5%,草乌5%,羌活5%,独活5%,丹参7.5%,红花6%,细辛5%,桂枝7.5%,川芎6%,冰片3%,乳香5%,没药5%。
本发明制剂以上中草药总重量比为百分之百
2.将上述16味中草药单味炮制合格,提纯、浓缩、称量配齐后,可加工成胶囊、颗粒、片剂、口服液等不同剂型。
病例介绍
陈××,河南省登封市人,干部,现年58岁。由于长期低头伏案工作,在20多年前就出现脖颈酸困疼痛、僵硬、肩部不适,后出现头晕、耳鸣、记忆力减退,记忆力下降等症状。被诊断为颈椎病。历年来,常服中西药,但没有明显效果,也曾按摩牵引,疗效也不理想。经用本发明制剂治疗,每次服胶囊6粒,一日三次。服用10天后,颈部疼痛和背部酸痛不适感明显减轻。服用一个月后,各种症状基本消失。
Claims (1)
1.一种治疗颈椎病的中药制剂,其特征是由葛根、威灵仙、枸杞子、天麻、川乌、草乌、羌活、独活、丹参、红花、细辛、桂枝、川芎、冰片、乳香、没药构成,它们的总重量比为百分之百时其中葛根15%、威灵仙8%、枸杞子6%、天麻6%、生草乌5%、川乌5%、羌活5%、独活5%、丹参7.5%、红花6%、细辛5%、桂枝7.5%、川芎6%、冰片3%、乳香5%、没药5%;本发明经炮制合格、提纯、浓缩、称量配齐后,可加工成胶囊、颗粒、片剂、口服液等不同剂型。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105697521A CN102475852A (zh) | 2010-11-25 | 2010-11-25 | 一种治疗颈椎病的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105697521A CN102475852A (zh) | 2010-11-25 | 2010-11-25 | 一种治疗颈椎病的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102475852A true CN102475852A (zh) | 2012-05-30 |
Family
ID=46088710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105697521A Pending CN102475852A (zh) | 2010-11-25 | 2010-11-25 | 一种治疗颈椎病的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102475852A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705681A (zh) * | 2014-01-14 | 2014-04-09 | 山东省千佛山医院 | 一种治疗颈椎病的中药贴剂 |
CN107158348A (zh) * | 2017-06-13 | 2017-09-15 | 湖南云从科技有限公司 | 一种用于颈椎病治疗作用药物配方及其制备方法 |
CN107596269A (zh) * | 2017-09-30 | 2018-01-19 | 张轩焜 | 一种治疗颈椎病的中药组合物及其制备方法 |
-
2010
- 2010-11-25 CN CN2010105697521A patent/CN102475852A/zh active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705681A (zh) * | 2014-01-14 | 2014-04-09 | 山东省千佛山医院 | 一种治疗颈椎病的中药贴剂 |
CN103705681B (zh) * | 2014-01-14 | 2018-03-13 | 山东省千佛山医院 | 一种治疗颈椎病的中药贴剂 |
CN107158348A (zh) * | 2017-06-13 | 2017-09-15 | 湖南云从科技有限公司 | 一种用于颈椎病治疗作用药物配方及其制备方法 |
CN107596269A (zh) * | 2017-09-30 | 2018-01-19 | 张轩焜 | 一种治疗颈椎病的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988657A (zh) | 一种治疗骨折及跌打损伤的膏药及其制备方法 | |
CN102940721B (zh) | 一种治疗慢性盆腔炎的药物 | |
CN104667244A (zh) | 一种治疗原发性痛经的足浴组合物 | |
CN102258658A (zh) | 活血止痛膏 | |
CN106309611A (zh) | 一种通筋活血膏药 | |
CN114306563B (zh) | 一种妇科更年期经方艾灸及其制备方法 | |
CN102526502A (zh) | 一种治疗重症肌无力的中药制剂 | |
CN103157017A (zh) | 一种治疗震颤麻痹的药物 | |
CN103191382A (zh) | 一种治疗痹症的药物及其制备方法 | |
CN100525827C (zh) | 一种内服治疗痛经中药组合物 | |
CN102961483B (zh) | 一种治疗腰腿痛的中药组合物及其制备方法 | |
CN102949680B (zh) | 一种治疗颈椎病的药酒及其制备方法 | |
CN102526259A (zh) | 一种治疗类风湿性关节炎的药物 | |
CN104491220A (zh) | 一种治疗带状疱疹的中药组合物 | |
CN102475852A (zh) | 一种治疗颈椎病的中药制剂 | |
CN101129736A (zh) | 治疗更年期综合征的一种中药组合物 | |
CN103989840A (zh) | 通督中药包 | |
CN102349980B (zh) | 一种治疗风湿病的中药 | |
CN102579750B (zh) | 一种治疗原发性痛经的中药组合物 | |
CN102526635A (zh) | 一种治疗经前期紧张综合症的药物及其制备方法 | |
CN102895610A (zh) | 一种治疗水肿的药物 | |
CN105031331A (zh) | 一种治疗痛经的肚脐贴剂及其制备方法 | |
CN104984148A (zh) | 一种临床用中药伤口护理组合物 | |
CN104095947A (zh) | 一种治疗肩周炎的中药制剂 | |
CN104288328A (zh) | 一种治疗带状疱疹的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120530 |